Standard Lithium
SLI · TSX
About SLI
- Employees
- 0
- Headquarters
- Vancouver, British Columbia
- Listed
- Sep 30, 1999
- Sector
- Materials
- Industry
- Metals & Mining
- Website
- standardlithium.com
SLI key statistics
- Market cap
- 510.84M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 2.23M
- Volume
- 929.64K
- Open price
- $1.47
- High today
- $1.50
- Low today
- $1.43
- 52 Week high
- $6.00
- 52 Week low
- $1.32
Standard Lithium (SLI) at a glance
As of Oct 23, 2026, Standard Lithium (SLI) shares are priced at $1.43, giving the company a market cap of 510.84M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $1.43 and $1.50. The current price is 0.0% above the day's low and 4.7% below its high.
Volume so far is 929.64K shares, below the average of 2.23M shares a day.
Over the past year Standard Lithium has ranged from $1.32 to $6.00, and now sits 2% of the way up that range.
Standard Lithium met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported -$0.0101 per share against an estimate of -$0.0141.
SLI earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 4 of the last 8 quarters, by 33.7% on average.
- Q3 FY24: reported -$0.06 per share against an estimate of -$0.067
- Q4 FY24: reported -$0.28 per share against an estimate of -$0.0567
- Q1 FY25: reported -$0.014 per share against an estimate of -$0.0442
- Q2 FY25: reported -$0.042 per share against an estimate of -$0.0324
- Q3 FY25: reported -$0.041 per share against an estimate of -$0.0345
- Q4 FY25: reported -$0.237 per share against an estimate of -$0.0196
- Q1 FY26: reported -$0.0102 per share against an estimate of -$0.0141
- Q2 FY26: reported -$0.0101 per share against an estimate of -$0.0141
SLI news
- Press releaseGlobe Newswire
- Press releaseGlobe Newswire
Standard Lithium Appoints Ralph Alexander to the Board of Directors
- Press releaseGlobe Newswire
Smackover Lithium Exceeds Targeted Customer Offtake Volumes for South West Arkansas Project
- Press releaseGlobe Newswire
Standard Lithium Announces Change to Board of Directors
- Press releaseGlobe Newswire
Smackover Lithium Announces Positive Preliminary Economic Assessment for the Franklin Project, Its First Lithium Project in East Texas
- Press releaseGlobe Newswire
Smackover Lithium Signs Binding Customer Offtake with LG Energy Solution for the South West Arkansas Project
- Press releaseBusiness Wire
Nano One and Standard Lithium Collaborate to Qualify Lithium Carbonate for LFP Cathodes
- Press releaseGlobe Newswire
Standard Lithium Demonstrates Successful Use of South West Arkansas Lithium Carbonate in North American LFP Battery Cells
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.